| Description | Arg-Gly-Glu-Ser acetate is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets. |
| In vivo | Arg-Gly-Glu-Ser (5 mg/kg) 与LPS或生理盐水+RGDS联用，对中性粒细胞和巨噬细胞数量无影响，并且与仅用LPS或生理盐水处理的小鼠相比，对蛋白质积聚无效果[1]。 |
| molecular weight | 507.49 |
| Molecular formula | C18H33N7O10 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Moon C, et al. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res. 2009 Mar 9;10:18. |
Arg-Gly-Glu-Ser acetate(93674-97-6 free base)
CAS No.:
Arg-Gly-Glu-Ser acetate is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activa
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.